Clinical Pharmacology Details


MECLIZINE


View Drug Forms

Indications & Dose:

Motion sickness; “possibly effective” in vertigo associated with diseases affecting vestibular system


BY MOUTH


Vertigo


PO 25 100 mg/day in divided doses, usually tid


Adult and Child >12 yr


• Motion sickness:


BY MOUTH


25 50 mg 1 hr prior to travel; may repeat qd for duration of journey


 

Contraindications:

Side Effects:

CNS: Drowsiness, excitation (paradoxical reaction in children), restlessness


CV: Hypotension, palpitations, tachycardia


EENT: Blurred vision, diplopia, dry nose, dry throat


GI: Anorexia, constipation, diarrhea, dry mouth, nausea, vomiting 


GU: Difficult urination, urinary frequency, urinary retention


SKIN: Rash, urticaria

Cautions:

Precautions:

Children <12 yr, glaucoma; obstructive Gl, GU disease;prostatic hypertrophy


Pregnancy ; used for treatment of nausea and vomiting during pregnancy; excretion into breast milk unknown

Interaction:

Drugs  Opiods derivaties

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: